What Are The Projected Market Size And CAGR For The Mechanical Circulatory Support Devices Market By The Conclusion Of 2030?
The mechanical circulatory support devices market size has grown rapidly in recent years. It will grow from $3.47 billion in 2025 to $3.82 billion in 2026 at a compound annual growth rate (CAGR) of 10.1%. The growth in the historic period can be attributed to limited availability of advanced circulatory support devices, reliance on conventional intra-aortic balloon pumps, increasing prevalence of heart failure, rising cardiac surgery procedures, lack of standardized training for device implantation.
The mechanical circulatory support devices market size is expected to see strong growth in the next few years. It will grow to $5.59 billion in 2030 at a compound annual growth rate (CAGR) of 10.0%. The growth in the forecast period can be attributed to technological advancements in pulsatile and non-pulsatile flow devices, growth in minimally invasive cardiac interventions, increasing adoption of left and biventricular assist devices, expansion of hospitals and specialty cardiac centers, rising investment in cardiac care research and development. Major trends in the forecast period include rising adoption of ventricular assist devices and total artificial hearts, growth in cardiac surgery and heart failure management procedures, increasing use of extracorporeal membrane oxygenation (ecmo) systems, focus on minimally invasive and percutaneous device implementation, enhanced regulatory compliance and safety standards for cardiac devices.
Claim Your Free Report Sample Today:
Which Drivers Are Expected To Support The Future Advancement Of The Mechanical Circulatory Support Devices Market?
The rising prevalence of heart failure is expected to propel the growth of the mechanical circulatory support devices market going forward. Heart failure is a chronic condition in which the heart cannot pump enough blood to meet the body’s needs. The rising prevalence of heart failure is due to the aging population, as older adults are more prone to cardiovascular diseases and related complications. Mechanical circulatory support devices help heart failure by assisting the heart’s pumping action, improving blood circulation, and easing the workload on the weakened heart. For instance, in September 2024, according to the Heart Failure Society of America (HFSA), a US-based non-profit organization, heart failure affects 6.7 million Americans over 20 now; by 2030, that number is expected to increase to 8.7 million, by 2040, to 10.3 million, and by 2050, to an astounding 11.4 million. Therefore, the rising prevalence of heart failure is driving the growth of the mechanical circulatory support devices market.
Which Segment Categories Are Influencing The Growth Trajectory Of The Mechanical Circulatory Support Devices Market?
The mechanical circulatory support devices market covered in this report is segmented –
1) By Type: Intra-Aortic Balloon Pump, Ventricular Assist Device, Total Artificial Heart, Extracorporeal Membrane Oxygenation
2) By Technology: Pulsatile Flow Devices, Non-Pulsatile Flow Devices
3) By Application: Cardiac Surgery, Heart Failure Management, Myocardial Infraction, Cardiogenic Shock
4) By End User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Other End Users
Subsegments:
1) By Intra-Aortic Balloon Pump: Percutaneous Intra-Aortic Balloon Pump, Surgical Intra-Aortic Balloon Pump
2) By Ventricular Assist Device: Left Ventricular Assist Device, Right Ventricular Assist Device, Biventricular Assist Device
3) By Total Artificial Heart: Pneumatic Total Artificial Heart, Electric Total Artificial Heart
4) By Extracorporeal Membrane Oxygenation: Venoarterial Extracorporeal Membrane Oxygenation, Venovenous Extracorporeal Membrane Oxygenation
What Trends Are Projected To Impact The Mechanical Circulatory Support Devices Market In The Coming Years?
Major companies operating in the mechanical circulatory support devices market are focusing on developing advanced technologies, such as magnetically levitated rotor (MAGLEV) technology, to provide patients with more reliable and efficient devices that enhance heart function and improve survival rates. Magnetically levitated rotor (MAGLEV) technology uses magnetic fields to suspend and spin a rotor without physical contact, reducing friction and wear for smoother, longer-lasting device performance. For instance, in July 2024, BiVACOR Inc., a US-based clinical-stage medical device company, launched the first-in-human implantation of its Total Artificial Heart (TAH). This innovative device is designed to completely replace both ventricles of a failing heart in patients with severe biventricular or univentricular heart failure who are not eligible for conventional left ventricular assist devices, providing a vital bridge-to-transplant solution that has the potential to improve survival and quality of life for thousands of patients facing limited treatment options due to the scarcity of donor hearts.
Which Organizations Are Considered Principal Leaders In The Mechanical Circulatory Support Devices Market?
Major companies operating in the mechanical circulatory support devices market are Abbott Laboratories, Medtronic Plc, Getinge AB, LivaNova PLC, Magenta Medical Ltd., CorWave SA, Jarvik Heart Inc., Carmat SAS, Procyrion Inc., BiVACOR Inc., Evaheart Inc., ReliantHeart Inc., SynCardia Systems LLC, Berlin Heart GmbH, NovaPump GmbH, CardiacAssist Inc., Circulite Medical Inc., Windmill Cardiovascular Systems Inc., NuPulseCV Inc., FineHeart SAS
Get Your In-Depth Mechanical Circulatory Support Devices Market Report Now:
Which Regions Are Generating The Highest Demand Within The Mechanical Circulatory Support Devices Market?
North America was the largest region in the mechanical circulatory support devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mechanical circulatory support devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Contact Us:
The Business Research Company: https://thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Comments
Post a Comment